Treatment for rheumatoid arthritis centers on stopping the immune system from attacking your joints, with the goal of reaching remission or at least low disease activity within about six months. The approach follows a “treat-to-target” strategy: your doctor sets a specific goal, monitors you every one to three months, and adjusts your medications if you’re not at least 50% better within three months. Most people start with the same first-line drug and escalate from there if needed.
Methotrexate as the First-Line Treatment
Methotrexate is the cornerstone of rheumatoid arthritis treatment and the first drug most people are prescribed. It works by blocking an enzyme that overactive immune cells need to function, which slows down the inflammation that damages your joints. The typical starting dose is 7.5 mg taken once a week, either as a pill or injection, and your doctor may increase it based on how you respond.
The catch is that methotrexate takes time. You can expect to notice improvement in about four to six weeks, though it may take longer to reach its full effect. During that waiting period, you’ll need regular blood and urine tests to make sure the drug isn’t affecting your liver or blood cell counts. Methotrexate is not safe during pregnancy, so if you’re a woman of childbearing age, a pregnancy test is standard before starting.
If methotrexate alone doesn’t get you to your target, your doctor may add a second conventional medication. Other options in this class include hydroxychloroquine (which takes two to four months to kick in), sulfasalazine (six weeks to three months), and leflunomide (four to eight weeks). These are sometimes combined with methotrexate rather than used as replacements.
Corticosteroids for Quick Relief
Because disease-modifying drugs take weeks or months to work, many people need something to control pain and swelling in the meantime. Low-dose corticosteroids, generally up to 10 mg of prednisolone per day, serve as a bridge during this gap. They reduce inflammation within hours to days, making the waiting period much more manageable.
The key principle with corticosteroids is to use them as briefly as possible. Guidelines recommend tapering off and stopping them as soon as your long-term medications take effect. Staying on corticosteroids for extended periods raises the risk of bone thinning, weight gain, and blood sugar problems. They’re also useful during flares, when a joint suddenly becomes more inflamed despite ongoing treatment.
Biologic Therapies
If conventional medications don’t bring your disease under control, the next step is a biologic. These are engineered proteins that target specific parts of the immune system driving your joint inflammation. There are four main classes, each working through a different mechanism.
- TNF inhibitors block a key inflammatory protein called tumor necrosis factor. This is the largest class, with five approved drugs including adalimumab, etanercept, and infliximab. They tend to work quickly, with some people noticing improvement within two to four weeks and continued gains over three to six months.
- IL-6 receptor blockers target interleukin-6, another inflammatory signal. Tocilizumab is the main drug here, with effects typically seen within four to eight weeks.
- T-cell costimulation blockers prevent a type of immune cell from becoming fully activated. Abatacept works this way, with responses usually appearing within three months.
- B-cell depleting agents reduce the number of B cells, another immune cell involved in joint destruction. Rituximab falls in this category, though its effects may not appear for up to three months after infusion.
Biologics are usually given as injections you do at home or infusions at a clinic, depending on the specific drug. Most are prescribed alongside methotrexate, which improves their effectiveness.
Biosimilars Can Lower the Cost
Biologic medications are expensive, but biosimilars offer a more affordable alternative. These are near-identical copies of original biologics that have been tested head-to-head against the originals and shown equivalent safety and effectiveness. In clinical trials, response rates for biosimilar versions of adalimumab and etanercept consistently matched those of the original drugs, with differences of only a few percentage points in either direction.
If your doctor recommends a biologic, it’s worth asking whether a biosimilar version is available. Multiple biosimilars for adalimumab and etanercept are now on the market, and choosing one can significantly reduce out-of-pocket costs without sacrificing results.
JAK Inhibitors: Effective but With Caveats
A newer class of drugs called JAK inhibitors (tofacitinib, baricitinib, upadacitinib) works differently from biologics. These are pills rather than injections, which many people prefer. They block signals inside immune cells that drive inflammation.
However, the FDA added its strongest safety warning to all three after a large clinical trial linked tofacitinib to increased risks of serious heart-related events like heart attack and stroke, certain cancers, blood clots, and death. Because of these findings, JAK inhibitors are now approved only for patients who haven’t responded to or can’t tolerate a TNF inhibitor. The risks are highest for current or past smokers, people with cardiovascular risk factors, and those with a history of cancer.
NSAIDs for Day-to-Day Symptoms
Nonsteroidal anti-inflammatory drugs like ibuprofen and naproxen reduce pain and swelling within hours and are often the first thing people reach for. They’re useful for managing symptoms, but they don’t slow joint damage. Think of them as comfort measures while your disease-modifying drugs do the real work. A reasonable trial period for any NSAID is a few weeks to a month to judge whether it’s helping enough.
Omega-3 Fatty Acids and Lifestyle
Fish oil supplements have modest but real evidence behind them for rheumatoid arthritis. Clinical trials have tested a range of doses. One notable study found that a daily dose of about 1.7 grams of EPA and 0.4 grams of DHA (the two active fats in fish oil) improved pain scores and patients’ overall assessment of their disease. These aren’t replacements for medication, but they may help reduce morning stiffness and general discomfort when used alongside your treatment plan.
Regular physical activity, particularly low-impact exercise like swimming, cycling, and walking, helps preserve joint mobility and reduces fatigue. Physical therapy can also teach you joint-protection strategies for daily tasks that put less stress on affected joints.
When Surgery Becomes an Option
Most people with rheumatoid arthritis never need surgery, but it becomes relevant when a joint doesn’t respond to medications. A synovectomy, which removes the inflamed tissue lining the joint, is typically considered when someone has improved overall after six months of drug therapy but still has one stubborn joint that remains swollen and painful. The best outcomes occur when the cartilage inside the joint is still largely intact.
If inflammation goes unchecked long enough to destroy the cartilage entirely, joint replacement surgery becomes the remaining option. This is most common in the knees and hips but can apply to smaller joints as well. The progression from chronic inflammation to cartilage destruction to joint replacement is exactly what the treat-to-target approach aims to prevent by catching inadequate treatment early and adjusting course.